Julien Capers
Algemeen Adviseur bij VERA THERAPEUTICS, INC.
Actieve functies van Julien Capers
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| VERA THERAPEUTICS, INC. | Algemeen Adviseur | 01-09-2022 | - |
Loopbaan van Julien Capers
Eerdere bekende functies van Julien Capers
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ZOGENIX, INC. | Corporate Officer/Principal | - | - |
Opleiding van Julien Capers
| Stanford University | Undergraduate Degree |
| UC Davis School of Law | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| General Counsel | 1 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| VERA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
- Beurs
- Insiders
- Julien Capers
- Ervaring
